{"organizations": [], "uuid": "8e54800f3138cc14c44774ee074c3ab35af6d868", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-intercept-pharma-says-us-court-gra/brief-intercept-pharma-says-u-s-court-granted-defendants-motion-dismissed-with-prejudice-derivative-lawsuit-purportedly-brought-on-behalf-of-company-idUSFWN1R811N", "country": "US", "domain_rank": 408, "title": "BRIEF-Intercept Pharma Says U.S. Court Granted Defendants Motion & Dismissed With Prejudice Derivative Lawsuit Purportedly Brought On Behalf Of Company", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-03-27T05:27:00.000+03:00", "replies_count": 0, "uuid": "8e54800f3138cc14c44774ee074c3ab35af6d868"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-intercept-pharma-says-us-court-gra/brief-intercept-pharma-says-u-s-court-granted-defendants-motion-dismissed-with-prejudice-derivative-lawsuit-purportedly-brought-on-behalf-of-company-idUSFWN1R811N", "ord_in_thread": 0, "title": "BRIEF-Intercept Pharma Says U.S. Court Granted Defendants Motion & Dismissed With Prejudice Derivative Lawsuit Purportedly Brought On Behalf Of Company", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters) - intercept pharmaceuticals inc", "sentiment": "neutral"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMA - U.S. COURT GRANTED DEFENDANTS MOTION & DISMISSED WITH PREJUDICE DERIVATIVE LAWSUIT PURPORTEDLY BROUGHT ON BEHALF OF COMPANY\n* INTERCEPT PHARMA SAYS LAWSUIT WAS FILED BY A STOCKHOLDER OF CO ON AUG 4, 2017 - SEC FILING Source text: ( bit.ly/2DWMGnS ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://bit.ly/2DWMGnS", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T05:27:00.000+03:00", "crawled": "2018-03-27T11:59:54.000+03:00", "highlightTitle": ""}